UNSPSC 51281614: Netilmicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H41N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O5J85GJJB, chemically known as o-(2,6-diamino-2,3,4,6-tetradesoxy-alpha-glycero-4-hexenopyranosyl-(1-4)-o-(3-desoxy-4-c-methyl-3-methylamino-beta-l-arabinopyranosyl-(1-6)-2-desoxy-n1-ethyl-d-streptamin but generally known as netilmicin, which bears US NIH Compound Identifier 41859.

UNSPSC 51281614 Netilmicin is a Commodity code nominally identifying a specific aminoglycoside antibiotic, but recent state and local solicitations tagged under this code show no procurement activity for netilmicin itself. Instead, the opportunities reflect broader pharmaceutical and medical supply purchasing: Seminole County, Florida is procuring naloxone and drug deactivation systems; the Texas Health and Human Services Commission is conducting exploratory market research on direct-to-manufacturer prescription programs; the City of Tampa is sourcing emergency medical and first aid supplies for its fire department; and the Minnesota Multistate Cooperative Purchasing Alliance is establishing contracts for generic multi-source pharmaceuticals and over-the-counter products. The code's actual use in state and local procurement diverges substantially from its nominal pharmaceutical identity, suggesting either mislabeling in the jurisdiction databases or use of the code as a catch-all for pharmaceutical and medical supply categories.

Issuing bodies span state agencies, counties, cities, and cooperative purchasing alliances, with activity concentrated in Florida, Texas, Minnesota, and Oregon. The City of Tampa's medical and first aid supplies procurement (IFB 26P00145, due March 13, 2026) represents the most concrete recent opportunity, a one-year term with renewal options valued at $700,000 designated as sheltered for certified Small Local Business Enterprises with a 5 percent bid discount cap of $10,000. The Minnesota MMCAP RFP (S1070000015802, due March 26, 2026) seeks multiple-award contracts for generic pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026. Seminole County's naloxone and drug deactivation system procurement (IFB 60459723LAS, due July 26, 2023 — note the significantly past deadline in the source record) calls for 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries. The code shows no concentration among repeat buyers and little signal of sustained netilmicin-specific demand in state and local procurement today.